Rethinking MASH 

Nov 16 2024
Convention Center: Ballroom 20 A
12:30 PM - 2:00 PM

World Class Speakers

Claude Sirlin, MD
Industry Presenter

Claude Sirlin, MD

University of California, San Diego
Niharika R Samala, MBBS
Industry Presenter

Niharika R Samala, MBBS

Indiana University
Mark Muthiah, MBBS
Industry Presenter

Mark Muthiah, MBBS

National University Hospital, National University of Singapore
Saima Ajaz, PhD
Industry Presenter

Saima Ajaz, PhD

King's College Hospital, London

Description

Since new nomenclature and novel treatments have been approved for MASH, there is a need for designing accurate pragmatic patient care pathways. This update focuses on the evidence-base behind precision markers and non-invasive tests in diagnosing, monitoring and prognosticating patients with or at risk of MASH. This symposium also explores the challenges of a holistic approach to MASH patients with competing comorbidities and multi-organ involvement as well as novel approaches involving lifestyle interventions. 

Supported by: Perspectum Ltd 

Orgainizer: HealthProMatch

For more information and to register, visit: https://healthpromatch.com/cme-event-nov-16/

Objectives

  • Understand new treatments available for MASH and analyze current evidence-base for non-invasive tests (NITs) in the diagnosis, monitoring and prognostication of patients with MASH
  • Reflect on how new treatments, NITs and PROMS in MASH can be incorporated into manageable patient pathways in primary and secondary care
  • Reflect on how to manage competing risks in patients with MASH
  • Consider the impact of MASH on population health and consider how non-pharmaceutical/ lifestyle interventions can be incorporated into patient pathways